KR20130093372A - Preparation method of oxyresveratrol, t-resveratrol, and moracin having anti-inflammatory and anti-aging function from mulberry twig extract - Google Patents
Preparation method of oxyresveratrol, t-resveratrol, and moracin having anti-inflammatory and anti-aging function from mulberry twig extract Download PDFInfo
- Publication number
- KR20130093372A KR20130093372A KR1020120014928A KR20120014928A KR20130093372A KR 20130093372 A KR20130093372 A KR 20130093372A KR 1020120014928 A KR1020120014928 A KR 1020120014928A KR 20120014928 A KR20120014928 A KR 20120014928A KR 20130093372 A KR20130093372 A KR 20130093372A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- ethanol solution
- ethanol
- mulberry
- resveratrol
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
Abstract
Description
본 발명은 항염증 및 항노화성 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신 함유 고품질의 상지추출물의 제조방법에 관한 것이다.
The present invention relates to a method for producing high-quality topical extracts containing anti-inflammatory and anti-oxidizing agents, such as oxirebazelor, trans-resveratrol and morasin.
식물분류학상 뽕나무는 Morus alba L. 로 표시되는 교목식물이다. 뽕나무(Mulberry)는 열매(桑子)로부터 잎(桑葉), 가지(桑枝), 뿌리껍질(桑白皮), 뽕나무에 기생하는 겨우살이(桑寄生), 상황버섯(桑黃), 누에(白蠶), 동충하초(冬蟲夏草)에 이르기까지 하나도 버릴게 없는 신목으로서 ‘동의보감’ 및 ‘본초강목’에는 고혈압과 동맥경화, 중풍을 비롯해 각기에 의한 부종, 신경통과 관절염, 감기의 기침과 가래 등에 효과가 있고, 자양강장 효과도 있는 것으로 적혀있다(약품식물학연구회, 신약품식물학, 학창사, p. 242, 1994; Tsuneo Namba 和漢藥百科圖鑑 I, 보육사, p 320, 1980).
Plant taxonomic Mulberry is an arboreal plant represented by Morus alba L. Mulberry is a kind of mulberry tree which is grown from a mulberry tree, a mulberry tree, a root bark, a mistletoe parasitic on a mulberry tree, a mulberry tree,蠶), and Dongchuhecho (冬蟲 夏草) as one of the 'Hyeonbokbo' and 'Hoseo gangmok' is a new breed of high blood pressure, arteriosclerosis, paralysis, edema by each other, neuralgia and arthritis, cold cough and sputum is effective (Tsuneo Namba: 百 百 百 鑑 鑑 鑑 鑑 鑑 鑑............................).
동의보감에는 뽕나무가지(상지)를 말려 만든 상지차는 풍습을 없애고 관절을 이롭게 하고 수기로 뼈마디가 쑤시고 저리는 풍한습비, 사지 비틀림, 기침, 중풍에 의해 입이 돌아가는 증상을 치료해 준다고 씌여져 있으며, 또한 몸이 비대한 사람은 살이 빠지는 효과도 있다고 한다. 또한, 상지는 편풍과 함께 모든 풍을 다스리고 소화를 촉진하고 기를 내리며, 입이 마르는 것을 다스린다고 적혀 있다. 일본 끽다양생기에는 상지를 넣어 만든 뽕죽은 당뇨병에 좋다고 기록되어 있다. 또한, 상지나 상백피를 달여 농축한 즙으로 빚은 상주(뽕가지술)는 약주로 쓰이는데 특히 중풍, 오체마비, 각기, 기침에 효험이 있다고 한다(Tsuneo Namba 和漢藥百科圖鑑 I, 보육사, p 320, 1980).
It is said that the upper tea made by drying the mulberry branches (upper body) is used to eliminate the customs, to help the joints, to bite the bones with the handwheel, to treat the symptoms caused by the abdominal torsion, limb twist, cough and paralysis. A person who is bloated is said to have the effect of losing flesh. In addition, the upper body is said to rule all the winds, to promote digestion, to lower the flame, and to control the dryness of the mouth with the edgewise. It is said that it is good for the diabetic mats who put up the upper part in the Japanese coffee cup curing period. In addition, it is said that the sangju (가지 가지 술 술)), which is made from the concentrated juice made from the sweet potatoes and the sesame oil, is effective for the paralysis, especially the paralysis, the otic paralysis, and the cough (Tsuneo Namba 和 漢 药 百科 圖書 I, 1980).
지금까지 알려진 상지의 생리적작용으로는 항간독성, 항산화, 항비만, 항염증, 항노화, 항관절염작용 등이 보고되었으며, 그 주된 생리활성성분으로서 prenylflavonoids, coumarin, stilbene 등이 알려져 있다(Oh et al., Planta Med 68: 932-934, 2002; Hu et al., J Nat Prod 74: 816-824, 2011; Kim et al., J Ethnopharmacol 136: 392-398, 2011; Chang et al., Food Chem Toxicol 49: 785-790, 2011).
So far, there is a physiological action of the known upper extremity have been reported include hanggan toxic, anti-oxidation, anti-obesity, anti-inflammatory, anti-aging, anti-arthritic action, known are such prenylflavonoids, coumarin, stilbene as the main bioactive components (Oh et al ., Planta Med 68: 932-934, 2002; Hu et al ., J Nat Prod 74: 816-824, 2011; Kim et al ., J Ethnopharmacol 136: 392-398, 2011; Chang et al ., Food Chem Toxicol 49: 785-790, 2011).
상지의 옥시레스베라트롤 및 레스베라트롤 등의 스틸벤(stilbene) 화합물과 모라신 등은 뽕나무 열매 오디 뿐만 아니라 상엽, 상백피 등 여러 잠상산물에도 존재한다(Kim et al., J Korean Soc Food Sci Nutr 37: 124-128, 2008; Kim et al., Korean J Seric Sci 47: 51-55, 2005; Piao et al., Phytochem Anal 22: 230-235, 2011, Kim et al., J Biol Chem 277: 16340-16344, 2002). 특히 상지의 옥시레스베라트롤은 피부 멜라닌 색소 생성을 촉진하는 티로시나제(tyrosinase)의 강력한 저해제로서 미백화장품 원료로 각광을 받고 있을뿐 아니라(Shin et al., Biochem Biophys Res Commun 243: 801-803, 1998; Oh et al., Arch Pharm Res 21: 703-706, 1998; Shimizu et al., Planta Med 66: 11-15, 2000; Chung et al., J Pharm Pharm 55: 1695-1700, 2003; Kim et al., J Biol Chem 277: 16340-16344, 2002) 염증성 매개물질인 엔오(NO) 생성 효소인 inducible nitric oxide synthase(iNOS)를 억제하고, 염증 촉진물질인 NF-kB 및 cyclooxygenase-2(COX-2) 활성을 억제하는 항염증물질로서 밝혀진 바가 있다(Chung et al., J Pharm Pharm 55: 1695-1700, 2003). 또한, 트란스-레스베라트롤은 포도와인의‘French Paradox'의 주된 물질로서(Ren명 Lorgeril, The Lancet 339: 1523-1526, 1992) 항암뿐 아니라, 항고혈압, 항염증, 항노화 및 항산화성 물질로 잘 알려져 있으며(Fremont Life Sci 66: 663-673, 2000), 최근에는 수명연장 효과도 있음이 보고된 바가 있다. 한편, 모라신유도체는 항당뇨뿐 아니라 항염증 및 항노화성 물질로 잘 알려져 있으며(Basnet et al., Chem Pharm Bull 41: 1238-1243, 1993; Lee et al., Biol Pharm Bull 25: 1045-10488, 2002), 특히 미백효능이 있는 항티로시나제 물질로서 보고(Lee et al., Biol Pharm Bull 25: 1045-10488, 2002)된 바가 있다.
Stilbene (stilbene) compound and the like of the upper extremity of the new Mora oxy resveratrol and resveratrol, such as are present in many products, such as latent image mulberries audio as well as reconstituted tobacco, Mori Cortex (Kim et al ., J Korean Soc Food Sci Nutr 37: 124-128, 2008; Kim et al ., Korean J Seric Sci 47: 51-55, 2005; Piao et al ., Phytochem Anal 22: 230-235, 2011, Kim et al ., J Biol Chem 277: 16340-16344, 2002). In particular, the topical oxir reseratrol is a powerful inhibitor of tyrosinase, which promotes the production of melanin pigment in skin, as well as a source of whitening cosmetics (Shin et al ., Biochem Biophys Res Commun 243: 801-803,1998; Oh et al ., Arch Pharm Res 21: 703-706,1998; Shimizu meat al ., Planta Med 66: 11-15, 2000; Chung et al ., < / RTI > J Pharm Pharm 55: 1695-1700, 2003; Kim et al, J Biol Chem 277:. 16340-16344, 2002) Inflammatory mediators in enoh (NO) synthase in inducible nitric oxide synthase (iNOS inhibiting) and inflammation promoting material NF- k B and cyclooxygenase-2 (COX -2) activity (Chung et < RTI ID = 0.0 > al ., J Pharm Pharm 55: 1695-1700, 2003). In addition, Trans-Resveratrol is a major component of the 'French Paradox' of grape wines (Ren Lorgeril, The Lancet 339: 1523-1526, 1992), as well as anti-hypertensive, anti-inflammatory, anti- (Fremont Life Sci 66: 663-673, 2000), and has recently been reported to have an extended life span. Moratin derivatives are well known as antidiabetic as well as antiinflammatory and antioxidative substances (Basnet et al., Chem Pharm Bull 41: 1238-1243, 1993; Lee et al., Biol Pharm Bull 25: 1045-10488 , 2002), in particular as an anti-tyrosinase substance having a whitening effect (Lee et al., Biol Pharm Bull 25: 1045-10488, 2002).
한편, 상지의 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신 등의 생리활성물질은 잠상산물에서 거의 대부분 배당체로 존재하며, 식물의 종류 및 품종, 산지, 계절 및 가공처리에 따라 그 함량이 천차만별이다(Kim et al., J Korean Soc Food Sci Nutr 37, 124-128, 2008; Kim et al., Korean J Seric Sci 47, 51-55, 2005; Piao et al., Phytochem Anal 22, 230-235, 2011). 특히 상지의 옥시레스베라트롤은 거의 대부분 배당체로 존재하며, 상백피의 주된 생리활성물질로 알려져 있으나 상엽이나 오디에는 거의 존재하지 않는다(Kim et al., J Korean Soc Food Sci Nutr 37, 124-128, 2008; Kim et al., Korean J Seric Sci 47, 51-55, 2005; Piao et al., Phytochem Anal 22, 230-235, 2011). 반면, 상지의 트란스-레스베라트롤(trans-resveratrol)은 오디뿐 아니라 상엽, 상백피에도 존재하며, 그의 이성질체인 시스-레스베라트롤(cis-resveratrol)과 함께 거의 대부분 배당체로 존재한다(Kim et al., J Biol Chem 277, 16340-16344, 2002). 모라신 성분도 상지를 비롯하여 오디, 상엽 및 상백피에도 함유되어 있으며, 대부분 배당체로 존재한다(Basnet et al., Chem Pharm Bull 41: 1238-1243, 1993).
On the other hand, the physiologically active substances such as oxyreservatol, trans-resveratrol and morazin in the upper limbs exist as almost all the glycosides in the latent products, and their contents vary depending on the kind of the plant, variety, mountain area, season and processing meat al ., J Korean Soc Food Sci Nutr 37, 124-128, 2008; Kim et al ., Korean J Seric Sci 47, 51-55, 2005; Piao et al ., Phytochem Anal 22, 230-235, 2011). Oxy-resveratrol in the upper limb is mostly present as a glycoside, and is known as the main physiologically active substance of the alfalfa, but it hardly exists in the upper leaves or the oti (Kim et al ., J Korean Soc Food Sci Nutr 37, 124-128, 2008; Kim et al ., Korean J Seric Sci 47, 51-55, 2005; Piao et al ., Phytochem Anal 22, 230-235, 2011). On the other hand, the upper extremity of trans-resveratrol (trans -resveratrol) is present, as well as mulberry mulberry, Morus, its isomers the cis-glycosides present in nearly all with resveratrol (cis -resveratrol) (Kim et al ., J Biol Chem 277, 16340-16344, 2002). Morraccal constituents are also present in the upper extremities, as well as in the oti, upper leaves and mantis (Basnet et al., Chem Pharm Bull 41: 1238-1243, 1993).
한편, 상지에 함유된 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신 성분들은 대부분 비활성형 배당체로 존재하고 있기 때문에 상지추출물을 그대로 사용할 때는 인체 흡수능이 낮을뿐 아니라 노화 억제 효능이 매우 낮다. 따라서 이들 생리활성물질이 실제로 항피부노화 기능을 충분히 발휘하기 위해서는 기존의 비활성형 성분을 활성형 성분으로 전환시키는 생물전환(Bioconversion)기술 개발이 필요하다.
On the other hand, since most of the components of oxir reseratrol, trans-resveratrol and morasin contained in the upper limb are present as inactive glycosides, when they are used as such, the absorption ability of human body is low and the effect of inhibiting aging is very low. Therefore, in order for these physiologically active substances to fully exhibit anti-aging function, it is necessary to develop a bioconversion technology that converts existing inactive components into active ingredients.
생물전환기술이란 발효에 의해 식물이 지니고 있는 비활성형 고분자물질을 활성형 저분자물질로 변형하거나 미생물이 생산하는 효소에 의해 기존의 활성형물질을 보다 고활성의 새로운 유도체를 생산방법으로서 피부 항노화 효능성분을 배가 시켜줄뿐 아니라 피부 깊숙한 곳까지 보다 많이 빠르게 흡수시켜 피부 노화를 억제하는 효과가 매우 크다. 최근 국내에서 생물전환기술을 이용한 항피부노화 기능성신소재의 개발이 활발히 이루어지고 있으며, 그 대표적인 예로서 콩의 isoflavone, 대황의 rhapontigenin 및 인삼의 ginsenoside 유도체 성분들은 현재 기능성화장품 소재로서 크게 각광을 받고 있다.
Biotransformation technology is a method of producing a new active derivative of an active substance by an enzyme produced by a microorganism or by converting an inactive polymer having a plant into an active low molecular substance by fermentation, It not only doubles the amount of ingredients but also absorbs more quickly into deep areas of the skin, which greatly reduces skin aging. In recent years, development of anti-aging functional materials using anti-aging technology has been actively developed in Korea. For example, isoflavone of soybean, rhapontigenin of rhubarb, and ginsenoside derivatives of ginseng have been widely recognized as functional cosmetic materials.
지금까지 상지를 포함한 잠상산물로부터 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신 유도체의 분리 및 동정 그리고 그들의 생리적작용에 관한 다수의 연구가 보고된(Shin et al., Biochem Biophys Res Commun 243, 801-803, 1998; Oh et al., Arch Pharm Res 21, 703-706, 1998; Shimizu et al., Planta Med 66, 11-15, 2000) 바가 있으나 비활성형이 아닌 활성형 항염증 및 항노화성 옥시레스베라트롤, 레스베라트롤 및 모라신 함유 고부가가치 상지추출물 제조에 관한 연구는 거의 없는 실정이다.
So far, a number of studies have been reported on the isolation and identification of oxyreservatol, trans-resveratrol and morazin derivatives from the latent images including the upper limb and their physiological actions (Shin et al ., Biochem Biophys Res Commun 243, 801-803, 1998; Oh et al, Arch Pharm Res 21, 703-706, 1998;.. Shimizu et al, Planta Med 66, 11-15, 2000) , but a bar-type anti-inflammatory activity than the inactive form and the chemical conversion hangno oxy resveratrol, resveratrol And mora-containing high-value upper limb extracts.
본 발명의 목적은 항염증, 항노화 기능성을 가진 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신이 함유된 뽕나무 가지추출물의 제조방법을 제공하는데 있다.
It is an object of the present invention to provide a method for producing mulberry tree branch extract containing oxyreservatrol, trans-resveratrol and morasin having anti-inflammatory, anti-aging function.
본 발명의 상기 목적은 상지의 찜처리 단계, 건조 상지의 에탄올 추출 단계, pectinex 효소에 의한 가수분해처리 단계, 에틸아세테이트 분획 단계, Diaion HP-20 흡착이온수지 칼럼 크로마토그래피를 수행하여 옥시레스베라트롤, 레스베라트롤 및 모라신 함유 상지추출물을 제조함으로써 달성하였다.
The above object of the present invention can be accomplished by a method for preparing a pharmaceutical composition comprising a step of steam treatment of the upper part, an ethanol extraction step of the dry upper part, a hydrolysis treatment step with pectinex enzyme, an ethylacetate fraction step and a Diaion HP-20 adsorption ion resin column chromatography to obtain ox res reseratrol, ≪ / RTI > and morragin-containing topical extracts.
이상 설명한 바와 같이 본 발명의 분리 및 정제방법은 뽕나무 가지로부터 항염증 및 항노화 기능성 옥시레스베라트롤을 함유하고 있는 정제분말을 대량생산할 수 있을 뿐만 아니라 항암, 항고혈압 및 항노화 기능성 트란스-레스베라트롤 및 모라신 성분을 기능성식품 및 화장품의 신소재로서 제공하는데 뛰어난 효과가 있다.
INDUSTRIAL APPLICABILITY As described above, the separation and purification method of the present invention is capable of mass-producing purified powder containing anti-inflammatory and anti-aging functional oxyreservatol from mulberry branches, as well as being capable of mass production of anticancer, antihypertensive and anti-aging functional trans- It has an excellent effect in providing the component as a new material for functional foods and cosmetics.
도 1은 항염증 및 항노화성 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신 함유 상지추출물의 제조방법을 나타낸 것이다.
도 2는 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신 함유 상지추출물의 고속액체크로마토그램 결과를 나타낸 것이다.Figure 1 shows a method for preparing anti-inflammatory and anti-oxidizing ox resveratrol, trans-resveratrol and topical extracts containing morasin.
FIG. 2 shows the results of high-performance liquid chromatography of oxyreservatrol, trans-resveratrol, and morassin-containing upper limb extract.
본 발명은 상지의 찜처리 단계, 건조 상지의 에탄올 추출 단계, pectinex 효소에 의한 가수분해처리 단계, 에틸아세테이트 분획 단계, Diaion HP-20 흡착이온수지 칼럼 크로마토그래피에 의한 옥시레스베라트롤, 레스베라트롤 및 모라신의 분리 및 정제 단계로 구성된다.
The present invention relates to a method for the treatment of ovari resveratrol, resveratrol and morazine by steam treatment of the upper limb, ethanol extraction of the dry upper part, hydrolysis treatment with pectinex enzyme, ethyl acetate fractionation, Diaion HP-20 adsorption ion resin column chromatography And a purification step.
본 발명은 다음의 단계를 포함하는 찜처리 상지로부터 옥시레스베라트롤, 레스베라트롤 및 모라신의 분리 및 정제방법을 제공한다. 상지를 찜통에 넣고 1시간 찜처리한 후 방냉하고 다시 열풍건조기에서 건조하여 건조 상지를 얻고, 건조 상지에 80% 에탄올수용액을(650 kg/100 kg 시료) 가하여 40 ~ 50℃에서 12시간 초음파추출기에서 추출한 다음 여과 및 감압농축하여 상지에탄올추출물을 얻었다.
The present invention provides a method for the isolation and purification of oxiresteral, resveratrol and morazine from the steaming tops comprising the steps of: The upper limb was placed in a steamer, steamed for 1 hour, cooled, and dried in a hot air drier to obtain a dry upper limb. An 80% aqueous ethanol solution (650 kg / 100 kg sample) , Followed by filtration and concentration under reduced pressure to obtain a topical ethanol extract.
상기의 상지추출물에 80% 에탄올수용액으로 다시 용해시킨 다음 일야 방치하여 얻은 상층에 2 배량의 100% 노르말-헥산을 첨가한 후 분획하여 탈지하였다. 상기에서 얻은 하층의 상지 탈지에탄올추출물을 부분 감압농축한 후 다시 추출물에 대해 5배 가량의 20% 에탄올수용액을 첨가하여 현탁시킨 후 여기에 상기 탈지 에탄올추출물에 대해 10% 펙틴나제 효소를 가하여 30 ~ 40℃에서 12시간 동안 가수분해시켰다. 상기로부터 얻은 가수분해물을 실온에서 방냉한 후 에틸아세테이트를 가하여 분획하여 얻어진 상층을 감압농축한 후 이온흡착수지 칼럼 크로마토그래피를 각각 수행하였다.
The upper limestone extract was dissolved again with 80% ethanol aqueous solution. The upper layer obtained by allowing to stand overnight was added with 2-fold amount of 100% n-hexane, followed by fractionation. The ethanol extract of the upper layer of the lower layer obtained above was partially concentrated under reduced pressure and then suspended in an aqueous 20% ethanol solution of about 5 times that of the extract. 10% pectinase enzyme was added to the defatted ethanol extract, Gt; 40 C < / RTI > for 12 hours. The hydrolyzate obtained from the above was allowed to cool at room temperature, and ethyl acetate was added to the reaction mixture. The resulting upper layer was concentrated under reduced pressure and subjected to ion-adsorption resin column chromatography.
상기에서 수득한 에틸아세테이트 분획물은 먼저 20% 에탄올수용액으로 용해시킨 다음 다이아이온 HP-20 이온수지에 흡착시킨 후 20% 에탄올수용액으로 칼럼을 충분히 수세한 후 다시 40% 및 60% 에탄올수용액으로 각각 용출시키고 농축하여 항염증 및 항노화성 옥시레스베라트롤, 레스베라트롤 및 모라신을 분리 및 정제한다.
The ethylacetate fractions obtained above were first dissolved in a 20% aqueous ethanol solution and adsorbed on a Diaion HP-20 ion resin. The column was washed thoroughly with 20% aqueous ethanol and then eluted with 40% and 60% aqueous ethanol And concentrated to separate and purify the anti-inflammatory and anti-oxidizing oxiresteral, resveratrol and morasin.
본 발명의 찜처리 상지로부터 옥시레스베라트롤, 레스베라트롤 및 모라신의 분리 및 정제방법에서 에탄올수용액의 바람직한 농도는 75% 내지 95%이며, 가장 바람직하게는 80% 내지 90% 에탄올수용액이다. 이 때 추출용매로써 에탄올 대신 메탄올을 사용할 수도 있다.
In the method of separation and purification of oxyreservatrol, resveratrol and morasin from the steamed upper part of the present invention, the preferred concentration of the aqueous ethanol solution is from 75% to 95%, most preferably from 80% to 90% aqueous ethanol solution. Methanol may be used instead of ethanol as an extraction solvent at this time.
본 발명의 찜처리 상지에서 옥시레스베라트롤, 레스베라트롤 및 모라신 성분의 분리 및 정제방법에서 가열추출의 바람직한 온도는 40℃ 내지 60℃ 이며, 가장 바람직하게는 50℃이다.
The preferred temperature for the heat extraction in the separation and purification method of oxyreservatrol, resveratrol and morasin components in the steamed upper part of the present invention is 40 캜 to 60 캜, and most preferably 50 캜.
이하, 본 발명의 구체적인 방법을 실시예를 들어 상세히 설명하고자 하지만 본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.
Hereinafter, the specific method of the present invention will be described in detail with reference to Examples, but the scope of the present invention is not limited only to these Examples.
실시예Example 1 : One : 찜처리Steam treatment , 효소처리, 용매분획 및 , Enzyme treatment, solvent fraction and 흡착이온수지Adsorption ion resin 칼럼 크로마토그래피에 의한 상지 에탄올추출물로부터 From the upper ethanol extract by column chromatography 옥시레스베라트롤Oxyresveratrol , , 레스베라트롤Resveratrol 및 And 모라신의Moral 분리 및 정제 Separation and purification
상지로부터 항염증 및 항노화성 옥시레스베라트롤, 레스베라트롤 및 모라신 을 분리 정제하기 위해 찜처리 상지 탈지에탄올추출물을 효소처리, 에틸아세테이트 분획, 및 Diaion HP-20 흡착이온수지 칼럼 크로마토그래피를 실시하였다. 우선, 상지를 찜통에 넣어 1시간 찜처리한 후 건조하여 얻은 건조 상지(Morus Twig) 100 kg에 80% 에탄올수용액 650 kg을 가하여 초음파추출기에서 50℃에서 12시간 동안 초음파추출한 후 여과하였다. 상기 추출과정을 2회 반복 실시하여 얻은 혼합 에탄올추출액을 부분 감압ㆍ농축하여 상지 에탄올추출물(10 kg)을 얻었다.
In order to separate and purify the anti-inflammatory and antinospermic oxys resveratrol, resveratrol and morasin from the upper limb, the ethanol extract of the steamed upper limb was subjected to enzyme treatment, ethyl acetate fractionation, and Diaion HP-20 adsorption ion resin column chromatography. First, the upper limb was steamed for 1 hour, and then dried. After 100 kg of Morus Twig was added with 650 kg of an aqueous 80% ethanol solution, the mixture was sonicated for 12 hours at 50 ° C in an ultrasonic extractor and filtered. The above extraction procedure was repeated twice, and the resulting mixed ethanol extract was partially decompressed and concentrated to obtain an upper ethanol extract (10 kg).
다음, 에탄올추출물에 80% 에탄올수용액(50 kg)을 가하여 용해시킨 후 하룻밤 실온에서 방치한 다음 얻어진 상등액을 분리한 다음 여기에 노르말-헥산(100 kg)를 가하고 교반하면서 분획하여 상층의 지방과 색소를 제거하고 하층을 감압농축하여 상지 탈지에탄올추출물(8.5 kg)을 얻었다.
Next, the ethanol extract was dissolved in an 80% ethanol aqueous solution (50 kg) and allowed to stand overnight at room temperature. The resulting supernatant was separated, and then normal-hexane (100 kg) was added thereto. Was removed and the lower layer was concentrated under reduced pressure to obtain an upper ethanol extract (8.5 kg).
이것을 다시 20% 에탄올수용액(50 kg)으로 현탁시킨 후 여기에 펙틴나제(pectinex 5 XL, Novozymes, Denmark) 4 L을 가하여 30 ~ 40℃에서 12시간 교반하면서 가수분해시킨 후 방냉한 다음 여기에 에틸아세테이트(100 kg)을 가하여 2회 반복 분획하여 얻어진 상층을 무수망초(10 kg)로 탈수하고 여과한 후 감압농축하여 에틸아세테이트추출물(2.1 kg)을 얻었다. 이것을 20% 에탄올수용액(5 kg)으로 현탁시킨 후 미리 20% 에탄올수용액으로 평형화시켜 놓은 Diaion HP-20 흡착이온수지(Mistubishi Chem. Co., Japan) 칼럼(10 cm × 50 cm)에 충진시킨 후 20% 에탄올수용액(40 L)로 충분히 수세한 후 40% 에탄올수용액(20 L) 및 60% 에탄올수용액(20 L)으로 각각 용출하였다. 이때 40% 에탄올수용액으로 용출되는 분획을 회전식 증발감압농축기(rotary evaporator)로 50℃ 이하에서 감압농축시켜 옥시레스베라트롤(순도: 60%)를 함유한 상지추출물 I(1.2 kg, 수율: 1.2%)을 얻었다.
4 L of
다음, 같은 방법으로 60% 에탄올수용액 분획으로부터 트란스-레스베라트롤(순도: 70%) 및 모라신(순도: 80%)를 함유한 상지추출물 Ⅱ(110 g, 수율: 0.11%)을 얻었다 (도 1).
(110 g, yield: 0.11%) containing trans-resveratrol (purity: 70%) and morasin (purity: 80%) were obtained from the aqueous 60% ethanol solution in the same manner .
실시예Example 2 : 본 발명의 방법에 따라 제조된 2: Preparation of < RTI ID = 0.0 > 상지추출물Upper limb extract I 및 Ⅱ 중의 I and II 옥시레스베라트롤Oxyresveratrol , , 트란스Trans -- 레스베라트롤Resveratrol 및 And 모라신의Moral 정량분석 Quantitative analysis
상기 실시예 1에 따라 제조된 상지추출물 I 및 Ⅱ 중의 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신의 정량분석은 고속액체크로마토그래피(HPLC)를 이용하여 다음과 같이 실시하였다. 우선, 상지 정제분말 1 g을 100% 메탄올 적절히 용해한 후 같은 용액으로 100 mL로 정용하였다. 상기 용액을 같은 용매로 10배 희석한 후 이 중 1 mL을 취하여 0.45 ㎛ membrane filter(gelman Sci, USA)를 통과시킨 후 20 ㎕를 HPLC에 주입시켜 정량분석하였으며, 이때 HPLC 분석은 워트스 e2690/5 고속액체크로마토그래피, 칼럼; YMC-Pack C18 (5 ㎛, 250 × 4.6 mm I.D., YMC Inc., USA), 이동상(용매 A --> 용매 B로 60분간 농도구배 용출); 용매 A(0.05% 인산) & 용매 B(100% 메탄올), 자외선 검출기; UV320 nm, 유속; 0.8 mL/min 조건으로 수행하였다.
Quantitative analysis of oxreservatol, trans-resveratrol and morasin in the upper limb extracts I and II prepared according to Example 1 was performed as follows using high performance liquid chromatography (HPLC). First, 100 g of methanol was appropriately dissolved in 1 g of the top-purified powder, and 100 mL of the same solution was used. The solution was diluted 10-fold with the same solvent, and 1 mL of the solution was passed through a 0.45 ㎛ membrane filter (gelman Sci, USA) and 20 μL was injected into the HPLC to quantitatively analyze the HPLC analysis. 5 high performance liquid chromatography, column; YMC-Pack C 18 (5 μm, 250 × 4.6 mm ID, YMC Inc., USA), mobile phase (concentration gradient elution for 60 min with solvent A -> solvent B); Solvent A (0.05% phosphoric acid) & Solvent B (100% methanol), ultraviolet detector; UV 320 nm , flow rate; 0.8 mL / min.
상기 실시예 1에 따라 제조된 상지로부터 분리된 옥시레스베라트롤(화합물 1), 트란스-레스베라트롤(화합물 2) 및 모라신(화합물 3)의 고속액체크로마토그램은 도 2에 나타내었으며, 각각의 화학구조는 다음과 같다.
The high-performance liquid chromatogram of oxyreservatrix (compound 1), trans-resveratrol (compound 2) and morazine (compound 3) isolated from the upper limb prepared according to Example 1 is shown in FIG. 2, As follows.
(화합물 1)(Compound 1)
(화합물 2)(Compound 2)
(화합물 3)(Compound 3)
그리고 상지로부터 분리된 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신의 화학구조 동정을 위해 먼저 3가지 화합물의 자외선 및 핵자기공명 스펙트럼을 측정하였고 아울러 전보(Shin et al., Biochem Biophys Res Commun 243: 801-803, 1998; Oh et al., Arch Pharm Res 21: 703-706, 1998; Kim et al., J Korean Soc Food Sci Nutr 37, 124-128, 2008)에 의해 이미 보고된 그들의 자외선 및 핵자기공명 스펙트럼과 비교분석을 통해 각 화합물을 동정하였다.
In order to identify the chemical structure of oxyreservatol, trans-resveratrol, and morasin isolated from the upper limb, ultraviolet and nuclear magnetic resonance spectra of the three compounds were first measured. Shin et al ., Biochem Biophys Res Commun 243: 801-803 , UV and nuclear magnetic resonance spectra (MICs) already reported by Oh et al ., Arch Pharm Res 21: 703-706, 1998, Kim et al ., J Korean Soc Food Sci Nutr 37, 124-128, And each compound was identified by comparative analysis.
상기 실시예 1에 따라 제조된 상지로부터 제조된 추출물 I 및 Ⅱ 중의 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신의 함량을 측정한 결과를 [표 1] 에 나타내었다.
Table 1 shows the results of measurement of the content of oxyreservatol, trans-resveratrol and morasin in the extracts I and II prepared from the upper limb prepared according to Example 1 above.
[표 1] 상지 탈지에탄올추출물을 효소처리, 에틸아세테이트 분획 및 [Table 1] Ethanol treatment of skim dipping ethanol treatment, ethyl acetate fraction and DiaionDiaion HPHP -20 -20 흡착이온수지Adsorption ion resin 칼럼 크로마토그래피 순으로 실시하여 제조된 Column chromatography to give < RTI ID = 0.0 > 상지추출물 Upper limb extract I 및 Ⅱ 중의 I and II 옥시레스베라트롤Oxyresveratrol , , 트란스Trans -- 레스베라트롤Resveratrol 및 모라신의 함량 And morashine content
상기 [표 1]에서와 같이 상지 탈지에탄올추출물을 효소처리, 에틸아세테이트 분획, 및 다이아이온 HP-20 칼럼 크로마토그래피 순으로 분리하여 제조된 정제분말 I 및 Ⅱ 중의 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신의 함량은 각각 60.50%, 40.64%, 및 45.16%이었고 수율은 정제분말 I이 1.2% 그리고 정제분말 Ⅱ가 0.11%를 얻을 수 있었다.
Trans resveratrol, trans-resveratrol and morazine in tablets Powder I and II prepared by sequential separation of the upper part defatted ethanol extracts with enzyme treatment, ethyl acetate fraction and Diaion HP-20 column chromatography as in the above Table 1 The contents were 60.50%, 40.64%, and 45.16%, respectively. The yields of purified powder I and purified powder II were 1.2% and 0.11%, respectively.
실시예Example 3 : 효소처리 유무에 따른 3: presence or absence of enzyme treatment 상지추출물의Topical extract 옥시레스베라트롤Oxyresveratrol , , 트란스Trans -- 레스베라트롤Resveratrol 및 모라신의 정량분석 And Moratin
상기 실시예 2에 의한 효소처리 유무에 따른 상지추출물에 함유된 4가지 생리활성물질(옥시레스베라트롤 3-O-베타-디글리코사이드, 옥시레스베라트롤, 트란스-레스베라트롤 및 모라신)을 정량하기 위해 앞서 HPLC 조건에 따라 비효소처리구의 탈지 에탄올추출물을 HPLC 분석한 결과 도 2와 같이 4가지 생리활성물질을 확인할 수 있었으며, 이때 미리 상지로부터 순수하게 분리된 4가지 생리활성물질을 이용하여 작성된 표준검량곡선[옥시레스베라트롤 3-O-베타-디글리코사이드: y=10.12x + 0.19 (r2=0.997), 옥시레스베라트롤: y=10.17x + 0.12 (r2=0.998), 트란스-레스베라트롤: y=6.78x + 0.08 (r2=0.997), 및 모라신: y=6.89x + 0.10 (r2=0.998)]을 토대로 효소처리 유무에 따른 상지 에탄올추출물 중의 4가지 생리활성물질의 함량을 측정한 결과는 [표 2] 와 같다.
To quantify the four physiologically active substances (oxyreservatrol 3- O -beta-diglycoside, ox resveratrol, trans-resveratrol and morasin) contained in the upper limb extract according to the presence or absence of the enzyme treatment according to Example 2, As shown in FIG. 2, four kinds of physiologically active substances were confirmed by HPLC analysis of the degreased ethanol extract of the non-enzyme treated group according to the conditions. At this time, a standard calibration curve prepared using four physiologically active substances, oxy resveratrol 3- O-beta-D glycoside: y = 10.12x + 0.19 (r 2 = 0.997), oxy resveratrol: y = 10.17x + 0.12 (r 2 = 0.998), trans-resveratrol: y = 6.78x + The results of measuring the contents of the four physiologically active substances in the upper ethanol extract according to the presence or absence of the enzyme treatment on the basis of 0.08 (r 2 = 0.997) and morasin: y = 6.89x + 0.10 (r 2 = 0.998) 2].
[표 2] 효소처리에 따른 [Table 2] 상지추출물Upper limb extract 중의 4가지 생리활성물질의 함량 비교 Comparison of the contents of four physiologically active substances
상기 [표 2] 에서와 같이, 비효소처리구 상지 에탄올추출물의 4가지 생리활성물질의 함량을 보면 옥시레스베라트롤 3-O-베타-디글리코사이드 43.82 mg/100 g , 옥시레스베라트롤(미량), 트란스-레스베라트롤 0.54 mg/100 g, 및 모라신 (미량) 으로서 옥시레스베라트롤 3-O-베타-디글리코사이드가 대부분 차지하고 있었으나 반면, 효소처리구에서는 옥시레스베라트롤 아글리콘 성분이 42.93 mg/100 g으로 대부분 차지하고 있었으며, 약간의 트란스-레스베라트롤 및 모라신이 존재하였다. 이와같이 효소처리에 의해 상지에 존재하는 옥시레스베라트롤 배당체 성분은 거의 아글리콘 성분으로 전환되었음을 확인하였다.As shown in Table 2, the contents of the four physiologically active substances of the ethanol extract of the non-enzyme-treated upper limb were 43.82 mg / 100 g of oxyresperatoric 3- O -beta-diglycoxide, ox resveratrol, Oxyreservatrol 3- O -beta-diglycoxide was the major component of resveratrol (0.54 mg / 100 g) and morasin (trace amount), while the enzyme treated group contained the majority of the oximes resveratrol aglycone component as 42.93 mg / 100 g, Some trans-resveratrol and mora were present. Thus, it was confirmed that the oxyreservatrix glycoside components present in the upper extremities were almost converted into aglycon components by the enzyme treatment.
Claims (3)
상기의 농축물을 80% 에탄올수용액로 다시 용해시킨 다음, 일야 실온에서 방치하여 침전물을 제거한 다음 여기에 노르말-헥산을 첨가하여 분획시켜 상층의 기름을 제거하고 하층은 다시 농축하고,
상기에서 얻은 상지 탈지에탄올추출물에 20% 에탄올수용액을 5배 가량 첨가하여 현탁시킨 후 상기 추출물에 대해 10% 펙틴나제 효소를 처리하여 30 ~ 40℃에서 12시간동안 가수분해시키고,
상기로부터 얻은 가수분해물을 에틸아세테이트 용매로 분획한 후 얻어진 상층을 감압농축한 후 다시 20% 에탄올수용액으로 용해한 후 다이아이온 HP-20 흡착이온수지 칼럼에 흡착시킨 후 먼저 20% 에탄올수용액으로 충분히 수세한 후 40% 에탄올수용액으로 용출시키고 농축하는 단계를 포함함을 특징으로 하는 옥시레스베라트롤 함유 상지추출물 제조방법.
The upper limb was steamed for 1 hour in a steamer and then dried. Ultrasonic wave was extracted for 12 hours at 40 to 50 ° C by adding 650 kg of a 75 to 95% ethanol aqueous solution to 100 kg of a dry upper limb (Morus Twig)
The concentrate was dissolved again in an aqueous 80% ethanol solution, and then allowed to stand at room temperature overnight to remove the precipitate, which was then fractionated by adding normal-hexane to remove the oil in the upper layer, and the lower layer was concentrated again.
Suspension was added by adding about 5 times of 20% ethanol aqueous solution to the obtained defatted ethanol extract, and then hydrolyzed at 30-40 ° C. for 12 hours by treating 10% pectinase enzyme with respect to the extract.
The hydrolyzate obtained above was fractionated with ethyl acetate solvent, the upper layer was concentrated under reduced pressure, dissolved in 20% ethanol solution, and then adsorbed on a DIION HP-20 adsorption ion resin column. After elution with 40% ethanol aqueous solution and oxyresveratrol containing upper limb extract characterized in that it comprises the step of concentrating.
The method according to claim 1, further comprising the step of eluting and concentrating the adsorbent ion resin with a 60% aqueous ethanol solution, and further comprising the step of concentrating the transabdominal upper limb extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120014928A KR101438543B1 (en) | 2012-02-14 | 2012-02-14 | Preparation method of oxyresveratrol, t-resveratrol, and moracin having anti-inflammatory and anti-aging function from Mulberry twig extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120014928A KR101438543B1 (en) | 2012-02-14 | 2012-02-14 | Preparation method of oxyresveratrol, t-resveratrol, and moracin having anti-inflammatory and anti-aging function from Mulberry twig extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20130093372A true KR20130093372A (en) | 2013-08-22 |
KR101438543B1 KR101438543B1 (en) | 2014-09-18 |
Family
ID=49217687
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120014928A KR101438543B1 (en) | 2012-02-14 | 2012-02-14 | Preparation method of oxyresveratrol, t-resveratrol, and moracin having anti-inflammatory and anti-aging function from Mulberry twig extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101438543B1 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160033063A (en) * | 2015-10-08 | 2016-03-25 | 고려대학교 산학협력단 | Pharmaceutical composition for prevention or treatment of blood vessel disease containing extracts of Morus alba stem having activity preventing from the atherogenic legion formation and foam cell formation |
WO2016159584A3 (en) * | 2015-04-03 | 2016-12-08 | 한국 한의학 연구원 | Composition for innate immunity enhancement and antiviral activity containing extract of mori ramulus or mori radicis cortex as active ingredient |
CN107788531A (en) * | 2017-11-10 | 2018-03-13 | 西华大学 | A kind of method that polyphenol is extracted in the fruit stone from mango |
KR101880081B1 (en) * | 2016-11-14 | 2018-07-19 | 농업회사법인 주식회사 이비채 | Method of fermented mulberry branch extract and beverage and cosmetics containing fermented mulberry branch extract by the same |
CN109645304A (en) * | 2018-12-28 | 2019-04-19 | 广东省农业科学院蚕业与农产品加工研究所 | A kind of preparation method of mulberry leaf material for healthy food |
CN111671177A (en) * | 2020-04-10 | 2020-09-18 | 中鸿纳米纤维技术丹阳有限公司 | Disinfection and sterilization mask with filtering layer applying biomass extracting solution |
CN112552147A (en) * | 2020-11-24 | 2021-03-26 | 菏泽学院 | Preparation method for extracting resveratrol from paeonia ostii seed meal |
CN112852462A (en) * | 2021-01-13 | 2021-05-28 | 中国石油大学(华东) | Continuous preparation method of oil-based raw material for mesophase pitch production |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101908772B1 (en) * | 2016-03-17 | 2018-10-16 | 대구가톨릭대학교산학협력단 | Anti-diabetic composition of mulberry twig hot water extract and oxyresveratrol as an efficient component and preparation method of the same |
KR20180062674A (en) * | 2016-12-01 | 2018-06-11 | 주식회사 유니바이오 | Method of extracting protein from mulberry leaves |
KR101967173B1 (en) | 2017-06-22 | 2019-04-09 | 대구가톨릭대학교산학협력단 | Composition comprising compounds isolated from Morus alba for preventing or treating of inflammatory disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100731613B1 (en) * | 2006-01-12 | 2007-06-22 | 코스맥스 주식회사 | Whitening and anti-aging cosmetic composition comprising stem heartwood extract of morus bombycis koidz |
KR100902094B1 (en) * | 2007-08-07 | 2009-06-09 | 한국생명공학연구원 | Pharmaceutical composition for the prevention and treatment of cancers containings extracts, fractions and isolated 2?arylbenzofuran compounds of Mori Cortex Radicis as an active ingredient |
KR20100056422A (en) * | 2008-11-19 | 2010-05-27 | 한국산업기술대학교산학협력단 | Cosmetic compositions for whitening skin comprising extracts from mulberry root hydrolyzed by enzymes |
-
2012
- 2012-02-14 KR KR1020120014928A patent/KR101438543B1/en active IP Right Grant
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016159584A3 (en) * | 2015-04-03 | 2016-12-08 | 한국 한의학 연구원 | Composition for innate immunity enhancement and antiviral activity containing extract of mori ramulus or mori radicis cortex as active ingredient |
KR20160033063A (en) * | 2015-10-08 | 2016-03-25 | 고려대학교 산학협력단 | Pharmaceutical composition for prevention or treatment of blood vessel disease containing extracts of Morus alba stem having activity preventing from the atherogenic legion formation and foam cell formation |
KR101880081B1 (en) * | 2016-11-14 | 2018-07-19 | 농업회사법인 주식회사 이비채 | Method of fermented mulberry branch extract and beverage and cosmetics containing fermented mulberry branch extract by the same |
CN107788531A (en) * | 2017-11-10 | 2018-03-13 | 西华大学 | A kind of method that polyphenol is extracted in the fruit stone from mango |
CN109645304A (en) * | 2018-12-28 | 2019-04-19 | 广东省农业科学院蚕业与农产品加工研究所 | A kind of preparation method of mulberry leaf material for healthy food |
CN109645304B (en) * | 2018-12-28 | 2022-04-05 | 广东省农业科学院蚕业与农产品加工研究所 | Preparation method of mulberry leaf health food base material |
CN111671177A (en) * | 2020-04-10 | 2020-09-18 | 中鸿纳米纤维技术丹阳有限公司 | Disinfection and sterilization mask with filtering layer applying biomass extracting solution |
CN112552147A (en) * | 2020-11-24 | 2021-03-26 | 菏泽学院 | Preparation method for extracting resveratrol from paeonia ostii seed meal |
CN112852462A (en) * | 2021-01-13 | 2021-05-28 | 中国石油大学(华东) | Continuous preparation method of oil-based raw material for mesophase pitch production |
Also Published As
Publication number | Publication date |
---|---|
KR101438543B1 (en) | 2014-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101438543B1 (en) | Preparation method of oxyresveratrol, t-resveratrol, and moracin having anti-inflammatory and anti-aging function from Mulberry twig extract | |
Thiruvengadam et al. | Production of anthraquinones, phenolic compounds and biological activities from hairy root cultures of Polygonum multiflorum Thunb. | |
Zhang et al. | Bioactive compounds in functional buckwheat food | |
Fu et al. | Enzyme assisted extraction of luteolin and apigenin from pigeonpea [Cajanuscajan (L.) Millsp.] leaves | |
CN100560579C (en) | Vaccinnium vitis-idaea extract and its production and application | |
Ye et al. | Isolation and free radical scavenging activities of a novel biflavonoid from the shells of Camellia oleifera Abel. | |
Senejoux et al. | Bioassay-guided isolation of vasorelaxant compounds from Ziziphora clinopodioides Lam.(Lamiaceae) | |
Lai et al. | Antioxidant, anti-inflammatory and antiproliferative activities of Kalanchoe gracilis (L.) DC stem | |
Shi et al. | Profiling of tyrosinase inhibitors in mango leaves for a sustainable agro-industry | |
JP2009531331A (en) | Extracts and methods comprising cinnamon seeds | |
Zou et al. | Unciflavones A–F, six novel flavonoids from Selaginella uncinata (Desv.) Spring | |
CN110638870A (en) | Method for co-producing multiple active substances from lotus leaves | |
KR20110052940A (en) | A process for preparing an extract fraction enriched with ginsenoside rg3 from ginseng radix | |
Liu et al. | Selenium-containing polysaccharides isolated from Rosa laevigata Michx fruits exhibit excellent anti-oxidant and neuroprotective activity in vitro | |
CN104983915B (en) | A kind of preparation method of black fruit fructus lycii natural composite antioxidant | |
KR101340081B1 (en) | Novel preparation method of Mulberry leaf extract for anti-hypertensive, anti-diabetic, and anti-aging and the product of the same | |
KR101963046B1 (en) | Composition of processed ginseng having increased ginsenoside compound K, chlorgenic acid and quercetin, and preparation method thereof | |
Wu et al. | Efficient extraction of caffeic acid derivatives from adventitious roots of Echinacea purpurea | |
CN109942385B (en) | Three new compounds in Japanese banana root and extraction and separation method | |
Chang-Tian et al. | In vitro antioxidant activities of Tussilago farfara, a new record species to Changbai Mountain | |
Lin et al. | Diarylheptanoids from the fresh pericarps of Juglans hopeiensis | |
KR100902669B1 (en) | A method for isolation and purification of calycosin from Astragali Radix | |
CN114081178B (en) | Rosa roxburghii pomace combined phenol with remarkable antioxidant activity and preparation method and application thereof | |
CN113546112B (en) | Method for extracting phenolic compounds from peony leaves and roots in classification manner | |
CN110078778B (en) | Method for removing prunasin from crude extract of passion fruit peel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20180830 Year of fee payment: 5 |